We also tested these biomarkers: monocyte chemoattractant protein-1 (MCP-1) and soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK), both involved in inflammation and atherothrombosis, among other processes [7–9]; galectin-3, related to malignancies, heart failure, thrombosis, and renal dysfunction [10,11]; and high-sensitivity cardiac troponin I, which has been described to have prognostic value in stable CAD [12]. Here, CCL2 is linked to Abnormal renal physiology.